A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Tuberculosis: follow-up of treatment without directed observed therapy (DOT) in a sanitary area Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
To study outcome of directly observered treatment shortcourse (DOTS) category I and category II relapses when put on re-treatment regimen (Cat-II DOTS) Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011
The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
Which method is effective in patient with asthma to guide the treatment? (2 year follow-up study) Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
Pilot project for DOTS implementation in sector IV, Bucharest, Romania: first 12 month analysis Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001
Video observed treatment for TB patients. Belarus experience. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
E-Health services for home monitoring and rehabilitation in COPD patients (preliminary report with 6 months follow up) Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
TB re-treatment results in relapses, default and failure – cohort study for 7 years Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis Year: 2006
When do we extend the treatment of tuberculosis (TB) more than 6 months? Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Results assessment after two years of pilot project for DOTS implementation in sector IV, Bucharest Source: Eur Respir J 2002; 20: Suppl. 38, 216s Year: 2002
Early experience with the implementation of the WHO shorter MDR-TB treatment regimen in Singapore Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Is DOTS-Plus effective and cost-effective? Source: Annual Congress 2007 - PG18 - New challenges in fighting tuberculosis in Europe Year: 2007
Therapeutic failure among incident users of ß-lactam antibiotics: a real-world, cohort study, in primary care in Italy Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR) Source: Annual Congress 2009 - Tuberculosis control Year: 2009
LTBI treatment completion rates in a unique academic center - public health department TB clinic model Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004
The long-term outcomes of a one-year Internet-based self-management support programme compared with usual care in asthma. Additional follow-up 1.5 year after a randomized trial Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011